Bumpus promoted; HUPO honors Kuster, Riley
Bumpus advances at FDA
Namandjé Bumpus has been named the principal deputy commissioner at the U.S. Food and Drug Administration. In this new leadership role with the FDA, she will work with a team to develop, advance and implement key public health initiatives and oversee the agency’s day-to-day operations.
Bumpus was previously the FDA’s chief scientist. In this role, she managed the research foundation, science and innovation that provides vital support for the agency’s public health mission. Before moving to the FDA, she ran a lab at Johns Hopkins University studying how P450 enzymes process antiretroviral drugs, which are used to treat human immunodeficiency virus, and antivirals used against hepatitis C.
Among her previous leadership roles, Bumpus served as associate dean for basic research and director of the pharmacology department at Hopkins and chair of a National Institutes of Health study section on xenobiotic and nutrient disposition and action. She has been president, treasurer, secretary and councilor of the American Society for Pharmacology and Experimental Therapeutics.
Bumpus’ awards and honors include the Leon I. Goldberg Award from the American Society for Clinical Pharmacology and Therapeutics, the James Gillette Award from the International Society for the Study of Xenobiotics, the John J. Abel Award in Pharmacology from the American Society for Pharmacology and Experimental Therapeutics and the Presidential Early Career Award for Scientists and Engineers. She is a fellow of the American Association for the Advancement of Science and a member of the National Academy of Medicine.
Küster and Riley win HUPO awards
Two American Society for Biochemistry and Molecular Biology members have been honored by the Human Proteome Organization. Bernhard Küster won the Distinguished Achievement in Proteomic Sciences Award for his ongoing contributions to the field of chemical proteomics. Nicholas Riley won the HUPO Rising Star Award, which recognizes early career researchers who have had an exceptional impact on the proteomics field and community.
Küster is a professor of proteomics and bioanalytics at the Technical University of Munich. His research focuses on the biochemical actions of therapeutic drugs, the molecular mechanisms that play a role in cancer and how information about these two aspects can be used for individual approaches to clinical treatment. Recently, his lab published a novel quantitative proteomic approach for decrypting drug actions and protein modifications by dose- and time-resolved proteomics.
Küster is a deputy editor of the journal Molecular & Cellular Proteomics. His past honors including the HUPO Discovery in Proteomic Sciences Award and the Mattauch-Herzog Award from the German Mass Spectrometry Society. The TUM Institute for Advanced Study named him the Carl von Linde Senior Fellow in 2018, and he was elected to the German National Academy of Science in 2019.
Riley is an assistant professor of chemistry at the University of Washington. The Riley research group investigates glycosylation patterns that govern health and disease using mass spectrometry-centric glycoproteomics and chemical glycobiology. His group is particularly interested in understanding how altered cell surface glycosylation phenotypes manifest in cancer progression and drive metastasis.
The Journal of Proteome Research recently named Riley a Rising Star in Proteomics and Metabolomics, and the American Society for Mass Spectrometry recognized him as an Emerging Talent in Academia.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition weekly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in People
People highlights or most popular articles
Guiding grocery carts to shape healthy habits
Robert “Nate” Helsley will receive the Walter A. Shaw Young Investigator in Lipid Research Award at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.
Leading the charge for gender equity
Nicole Woitowich will receive the ASBMB Emerging Leadership Award at the 2025 ASBMB Annual meeting, April 12–15 in Chicago.
Honors for de la Fuente, Mittag and De La Cruz
César de la Fuente receives the American Society of Microbiology’s Award for Early Career Basic Research. Tanja Mittag and Enrique M. De La Cruz are named fellows by the Biophysical Society.
In memoriam: Horst Schulz
He was a professor emeritus at City College of New York and at the CUNY Graduate Center in Manhattan whose work concentrated on increasing our understanding of mitochondrial fatty acid metabolism and an ASBMB member since 1971.
Computational and biophysical approaches to disordered proteins
Rohit Pappu will receive the 2025 DeLano Award for Computational Biosciences at the ASBMB Annual Meeting, April 12-15 in Chicago.
Join the pioneers of ferroptosis at cell death conference
Meet Brent Stockwell, Xuejun Jiang and Jin Ye — the co-chairs of the ASBMB’s 2025 meeting on metabolic cross talk and biochemical homeostasis research.